Connect with us

Media & Technology

The Powerful Run on Northwest Biotherapeutics, Inc (OTCMKTS: NWBO)

Published

on

Northwest Biotherapeutics, Inc (OTCMKTS: NWBO) has emerged as one of the most exciting stories in small caps in recent months seeing its stock skyrocket from $0.14 lows earlier this year to recent highs of $2.51 per share. For years NWBO showed huge promise but the stock went nowhere and attracted many long suffering longs who are now up at least 7 X their money.

NWBO recently saw a powerful move as the Company reported Data Lock for the Phase III trial of DCVax®-L for Gliobastoma. This comes after a long 13 – year wait for investors. Expectations are sky high for DCVax-L; unique because it doesn’t target one particular antigen, but uses the patient’s own tumour specimen to create the vaccine. Glioblastoma multiforme (GBM) is the most aggressive form of brain cancer and represents a potential market expected to reach $1.4 billion by 2025. A cornerstone of NWBO expanding program is completion of the buildout of the Sawston, UK manufacturing facility.

Northwest Biotherapeutics, Inc (OTCMKTS: NWBO) is developing cancer vaccines designed to treat a broad range of solid tumor cancers more effectively than current treatments, and without the side effects of chemotherapy drugs.  NW Bio’s proprietary manufacturing technology enables the Company to produce its personalized vaccine in an efficient, cost-effective manner. NW Bio has a broad platform technology for DCVax dendritic cell-based vaccines. NW Bio recently completed the acquisition of Flaskworks for $4.33 million, of which $1.65 million was paid in cash at closing. Flaskworks has developed a breakthrough system to close and automate the manufacturing of cell therapy products such as DCVax®.  It is anticipated that the Flaskworks system will enable substantial scale-up of production volumes of DCVax products and substantial reduction of production costs. Flashworks technical team has joined NW Bio as part of the acquisition.

NW Bio lead product, DCVax-L, is in Data Lock for the Phase III trial of DCVax®-L for Gliobastoma. Glioblastoma multiforme (GBM), the most aggressive and lethal brain cancer. Bio has also conducted a Phase I/II trial with DCVax-L for late stage ovarian cancer together with the University of Pennsylvania.

NW Bio second product, DCVax-Direct, is currently in a 60-patient Phase I/II trial for direct injection into all types of inoperable solid tumor cancers, with trials currently being conducted at both MD Anderson Cancer Center in Texas, as well as Orlando Health in Florida.  NW Bio previously received clearance from the FDA for a 612-patient Phase III trial with its third product, DCVax-Prostate, for late stage prostate cancer.

Many, many patients have claimed DCVAX saved their lives including Alice a Metastic Merkel Cell patient from Florida. Brad Silver a GBM patient from Huntington Beach, California. Sarah Rigby a GBM patient from Hong Kong. Kristyn Power, the daughter of GBM patient from Canada. Kat Charles GBM patients from UK as related by her husband Jason (Kat’s Cure)

To Find out the inside Scoop on NWBO Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

NWBO

There have also been many media stories about DCVAX saving people’s lives including articles in NBC Channel 4 and a number of print magazines. NWBO – National Geographic’s Allan Butler Stage IV Pancreatic Patient using DCVax-Direct at MD Anderson. NWBO GBM Brain Cancer Survival Story of Mark Pace. NWBO GBM Brain Cancer Suvivial Story of Brad Silver. NWBO, GBM Brain Cancer Survival Story of Mike Gregoire. UCLA – Real Stories Using DCVax.

On October 5 NWBO announced the database for the Phase III trial of DCVax®-L for Gliobastoma has been locked. With the database now locked, the independent service firms managing the Clinical Trial are arranging for the independent statisticians to have access to the unblinded raw data from the Trial.  Neither the Company nor any party other than the independent statisticians will have access to any unblinded data at this stage.

NWBO CEO Linda Powers stated: “We are excited to be so close to the finish line now, after such a long road. We are hopeful that DCVax®-L can become an important new treatment option for patients who urgently need more and better treatments for Glioblastoma brain cancer. We are grateful to the independent service firms and the clinical trial sites who have worked so hard to complete the data collection and confirmation during many months of COVID restrictions and challenges. We are also very grateful to our shareholders for their patience and support, which has made all this possible.”

Linda Powers previously stated “The UCLA Brain Tumor Program continues to shine as a beacon of hope, carrying a record of patients with brain tumors living longer than patients treated at any other hospital. Our personalized brain cancer vaccine, DCVax, is the first of its kind and is currently in Phase III clinical trials in 46 centers throughout America. It is on the road to FDA approval as well as clinical trials throughout Europe.  Using this vaccine, we are harnessing the patient’s immune system, genetics, pathology, brain mapping and a wide database of bioinformatics to optimize outcomes.”

 

For the very latest on  NWBO Subscribe Right Now!

NWBO has emerged as one of the most exciting stories in small caps in recent months seeing its stock skyrocket from $0.14 lows earlier this year to recent highs of $2.51 per share. For years NWBO showed huge promise but the stock went nowhere and attracted many long suffering longs who are now up at least 7 X their money. NWBO recently saw a powerful move as the Company reported Data Lock for the Phase III trial of DCVax®-L for Gliobastoma. This comes after a long 13 – year wait for investors. Expectations are sky high for DCVax-L; unique because it doesn’t target one particular antigen, but uses the patient’s own tumour specimen to create the vaccine. Glioblastoma multiforme (GBM) is the most aggressive form of brain cancer and represents a potential market expected to reach $1.4 billion by 2025 as NWBO are well aware of. A cornerstone of NWBO expanding program is completion of the Phase I buildout of the Sawston, UK manufacturing facility. It has been noted that after all this data and blinded information readily available, a redefined SAP that allows for comparison to contemporaneous trials, and even if the worse-case scenario of the overall survival not meeting the two month increase, there is still enough positive outcomes from this trial that this would readily provide Linda Powers and her board ample bargaining power to sell NWBO’s proprietary vaccine to the highest bidder, which would readily be in the $10 to $20 billion market cap range.” Microcapdialy has been covering NWBO since the stock was $0.15 per share. We will be updating on NWBO when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with NWBO.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in NWBO either long or short and we have not been compensated for this article.

Continue Reading
4 Comments

4 Comments

  1. Chris Lonsford

    November 15, 2020 at 7:35 pm

    Recent high was 2.51 not 0.51

    • Justin Kinney

      November 15, 2020 at 7:40 pm

      Thanks Longsford. Anyone else have anything to add?

  2. joe pratt

    November 15, 2020 at 10:24 pm

    https://www.dropbox.com/sh/tlagm94xvkr4eah/AADYWl2TLEu9wzG5P1-nPp9ja?dl=0&preview=Cognate+PILOT+Application.pdf

    By Greg Akers – Editor-in-Chief, Memphis Business Journal
    Nov 13, 2020, 3:04pm CST Updated Nov 13, 2020, 3:29pm CST
    A bioscience company with a large local presence is planning a new investment that would create hundreds of jobs and see three industrial sites receive major renovations and new construction.

    Cognate BioServices Inc. plans to renovate three properties for “cell-therapy operations, contract development, and manufacturing for drug sponsors, and related logistics.”

    The company is seeking a 15-year Jobs PILOT (payment-in-lieu-of-taxes) from the Economic Development Growth Engine (EDGE) for Memphis and Shelby County. The incentive would be worth $52 million, and be based on a $212 million project investment.

    The investment would include $126 million in construction costs and $71 million in personal property. It covers sites at 4600 E. Shelby Drive, 5780 E. Shelby Drive, and 6100 Global Drive.
    See ihub 330449
    https://microcapdaily.wpengine.com/the-powerful-run-on-northwest-biotherapeutics-inc-otcmkts-nwbo/128611/

  3. joseph H pratt

    November 15, 2020 at 10:26 pm

    ae kusterer Sunday, 11/15/20 09:24:24 PM
    Re: None 0
    Post #
    330550
    of 330554

    COULD IT BE THAT NWBO WILL LICENSE THE FLASKWORKS TECHNOLOGY TO COGNATE?

    https://nwbio.com/northwest-biotherapeutics-acquires-flaskworks-breakthrough-automation-technology-for-cell-therapy-products-to-enable-scale-up-of-production-volumes-and-reduction-of-production-costs/

    “The Flaskworks system will follow the same batch-manufacturing process – doing so in a “closed” and automated manner.

    Certain optimization work will be required so that the Flaskworks system will produce DCVax-L products with characteristics equivalent to the products made by the current DCVax-L manufacturing processes. This will then need to be confirmed by comparability studies. The Flaskworks technical team will work with NW Bio’s contract manufacturers to accomplish this. In the meantime, the Company’s DCVax products will continue to be made through the existing processes.”

    https://www.dropbox.com/sh/tlagm94xvkr4eah/AADYWl2TLEu9wzG5P1-nPp9ja?dl=0&preview=Cognate+PILOT+Application.pdf

    http://www.growth-engine.org/news/events/wednesday-november-18-2020-edge-board-meetings/

    https://www.bizjournals.com/memphis/

    KaOsiris Friday, 11/13/20 04:57:54 PM
    Re: None 0
    Post #
    330131
    of 330199
    Cognate BioServices plans $212M investment in Memphis ops

    Memphis Business Journal

    By Greg Akers
    Editor-in-Chief, Memphis Business Journal
    Nov 13, 2020, 3:04pm CST
    Updated 26 minutes ago

Leave a Reply

Your email address will not be published. Required fields are marked *

Featured

Creatd, Inc. (OTCMKTS: CRTD) Stock Price Continues to Deteriorate as the Legal Battle with The Lind Partners, LLC Continues

Published

on

Creatd, Inc. (OTCMKTS: CRTD) share value continues to drop after a brief recovery in mid-March. The firm’s stock is still not at the lowest point it has ever been, but it is not too far off at this point. The lowest that the shares have gone was $0.0457, which is the point they reached on October 11th, 2022. After that, in the final months of the previous year, the stock price shot up, reaching $1.6941 per share on November 18th.

The last time when the shares reached this height was in February 2022. However, back then, the price was rapidly spiraling down from a much higher point. Unfortunately for the company and its investors, after reaching $1.6941 in November, the share price crashed in a sharp correction, sinking to $0.50 by the end of November.

CRTD found a strong support at this level, which allowed it to bounce back up to $0.90, which is where the company encountered a strong resistance. It kept bouncing back and forth between these two levels throughout December 2022 and January 2023. However, as time passed, the fluctuations were becoming smaller, as the price seemingly started achieving greater stability. Looking back now, however, it becomes clear that the volatility may have decreased, but the overall trend became bearish somewhere in mid-January.

To Find out the inside Scoop on CRTD, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

CRTD price was dropping again, and in the second half of February, it broke the support level at $0.50, sinking to $0.16 by February 27th. After briefly recovering in early March, the price went back up to $0.3, encountering a resistance here, as well, which pushed it back down to $0.1156 this time, which was on March 14th. In the last 48 hours, the price managed to recover a bit once more, sitting at $0.15 at the time of writing.

Creatd, Inc. (OTCMKTS CRTD) stock price continues to deteriorate as the legal battle with The Lind Partners, LLC continues

Creatd, Inc. (OTCMKTS: CRTD) stock has seen a rough performance over the last year, with only a brief period of recovery in November 2022. Other than that, the last 12 months were marked by nothing but price crashes triggered by various events that followed the company. In recent months — specifically in December — the company announced an upcoming merge with Global Tech Industries, albeit without disclosing the terms of the deal. After that, reports said that Global Tech Industries had decided to bid $100 million in stock in order to acquire Creatd. Creatd even halted any discussions with other potential acquirers for 30 days as part of the LOI. At the time, its CEO and Chairman, Jeremy Frommer, said:

There are two elements to this merger, fundamental and technical. The opportunity to advance the Creatd business model and scale revenues coupled with the unique technical position we find our two public companies in, is a momentous opportunity. At the time of closing of any proposed transaction, GTII share delivery to Creatd shareholders will only occur in instances of registered ownership with the transfer agent or DTC.

For a time, everything was going well for the company until February 24th, when reports emerged that Creatd had terminated the proposed acquisition discussions with Global Tech. This was what triggered the stock crash, as many were disappointed that the deal did not succeed.

Around that time, the company was also struggling with a potential illegal naked short selling, and it launched CEOBLOC to try and fight it. One positive development at the time was the fact that CRTD became available on Upstream, which marked the third issuer to dual-list their shares on Upstream’s blockchain-powered market.

https://twitter.com/UpstreamXchange/status/1625520006770618368

However, the stock was hit with another blow a week ago when Creatd released an update regarding its legal dispute with The Lind Partners, LLC, and the company’s affiliates. The dispute concerns a convertible promissory note that amounts to $900,000.

For more on CRTD Subscribe Right Now!

According to Lind, Creatd breached certain representations and warranties in regard to the note. Lind demanded immediate repayment of the full amount, but Creatd instead decided to offer a number of alternatives. Lind refused to negotiate and Creatd filed a motion to dismiss. The company’s CEO said:

At this early stage, we are strictly trying to analyze data. There is more than enough evidence that there has been unusual trading in CRTD and it demands further investigation. To that end, we have asked legal counsel to look into filing multiple requests of trading records from market makers in CRTD stock. When and if the Company enters the discovery period in The Lind Partners, LLC case, any trading records related to The Lind Partners, LLC that were done with external broker dealers will also be analyzed.

Creatd, Inc. (OTCMKTS: CRTD) is a holding company that offers new economic opportunities to creators using partnerships and technology. The company’s goal is to empower creators and brands, and it claims that each of its companies shares a common mission — to create technologies and develop partnerships that would allow it to unlock new opportunities useful to entrepreneurs, brands, and creators, allowing them to also grow creatively, sustainably, as well as profitably.

For the moment, it appears that the situation is not the best for the company. It is in the middle of legal proceedings, its merger has failed, and its stock is one bad day away from reaching its all-time low. The chart above shows that CRTD is willing to grow and ready to jump on any opportunity, so the company still has a chance. Any piece of good news would likely send its stock to the path of recovery, which is why it is still worth keeping an eye on future developments. We will be updating on CRTD when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with CRTD.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by Sang Hyun Cho from Pixabay

Continue Reading

Featured

Global Developments Holdings, Inc (OTCMKTS: GDVM) Share Starts Recovery After a Second Big Drop in Three Months

Published

on

Global Developments Holdings Inc (OTCMKTS: GDVM) share has steadily risen for the past six and a half months. The company’s performance in 2023 has been remarkable.

Global Developments Holdings Inc (OTCMKTS: GDVM) share has been on a steady rise for the past six and a half months. The company’s performance in 2023 shows that the share was growing, then it saw a sudden surge, only to crash back down. However, the company’s 6M chart clearly indicates that the share has been rising steadily, and both rapid surges followed by sudden crashes — one in November/December 2022 and another in February 2023 — were only brief pumps. The stock’s performance overall still indicates that GDVM is seeing a strong, steady rise, which was not affected by these instances of strong volatility.

The GDVM price was fairly stable for the first eight months of 2022, slightly fluctuating around $0.0040. However, at the end of August 2022, the price started to grow. The growth was steady, healthy, and the price kept going up, almost completely uninterrupted until November 3rd. At the time, it reached $0.0527, but after reaching this level, it saw a slight correction to a support at $0.040. After only about a week at this level, a rapid surge took it all the way up to $0.1109. The surge started around November 16th, and it reached its peak by December 6th.

After that, a rapid correction made the price crash back down to $0.056 later on the same day. After an attempt at recovery, the price dropped again on December 14th, this time sinking to $0.038. From there on, the price managed to return back to its steady growth, which actually lasted until late January 2023. At the time, it reached $0.066, when another surge took place, starting on January 27th.

To Find out the inside Scoop on GDVM, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

In the following month, the price climbed up to $0.1359, reaching this height on February 23rd, which was once again followed by a rapid crash back to $0.0726. What followed was a few weeks of stability, which led the price to finally grow back up again, to $0.0862, on March 9th. This was followed by another mild correction to $0.769, which is where the GDVM price sits right now at the time of writing.

Global Developments Holdings, Inc (OTCMKTS GDVM) Share Starts Recovery After a Second Big Drop in Three Months

Global Developments Holdings, Inc (OTCMKTS: GDVM) price behavior has been quite significant over the last six months. However, it is also worth noting that most of these developments — the beginning of the six-month steady growth, as well as rapid price surges in between — took place when some major developments for the company happened. For example, the price started climbing up in August after reports that it reduced OS by 525 million, with rumors that significant moves are being made behind the scenes. At the time, it was rumored that the company was planning a reverse merger, which is exactly what it was doing, as it was discovered later on.

Following that, reports in November emerged, noting that the reverse merger is heating up, especially as the new CEO was affected by massive share reduction. The merger was with a company VeeMost, and by early December 2022, it achieved its 4th advanced specialization. At the time, reports were also praising GDVM as its stock price continued to skyrocket. The stock has been under heavy accumulation from the moment Mr. Melvin Ejiogu, an executive who also acts as President of VeeMost Technologies, became the controlling shareholder. He said:

$GDVM majority control acquired and all outstanding debt purchased. I also purchased 12% of outstanding shares and returned them to the treasury. No dilution will occur. I’ll be sharing updates soon with everyone on our new journey.

His new dilution policy affected a massive share reduction, as mentioned, and trapped the market makers, who were seriously short. The reverse merger stocks have proven that they can be much more explosive than biotechs, assuming that the incoming company has real value. By mid-February, Global Developments became the highest overall rated company in the Shell Companies industry. It had an overall score of 66 while and an average score of 43. This means that, on average, the stock in this industry tends to score higher than 43% of the stock market. However, according to Ejiogu’s tweet published on February 17th, he was working on getting the shell status removed from GDVM.

Global Developments Holdings, Inc (OTCMKTS: GDVM) is a company that provides expert consulting for businesses. It is a principal investment firm that specializes in acquisitions and early-stage financing of emerging growth companies. It describes its service as fast and reliable, and it can help whether its clients need help with finances, advice on theoretical matters, or assistance with practical tasks.

For more on GDVM Subscribe Right Now!

It has a highly-qualified team that is happy to assist with any needs in both private and commercial spheres. The company is based in Delaware, and it was incorporated on December 9th, 2004, as Autobahn International, Inc. However, in 2016, it rebranded to Global Developments Inc and then once more to Global Developments Holdings, Inc, on September 20th, 2018.

For the time being, the company’s stock is still growing steadily after starting to increase in August of last year. The past price surges, followed by sharp corrections, are fairly normal behavior. Prices tend to surge after beneficial developments, and a sharp rise is always followed by a sharp correction. The positive thing is that the price continues to increase after the correction is over, and the chart above clearly shows that the company continues to thrive under the new leadership. We will be updating on GDVM when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with GDVM.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have no position in GDVM and have not been compensated for this article.

Image by David Mark from Pixabay

Continue Reading

Featured

Asia Broadband, Inc (OTCMKTS: AABB) Stock Price Surges as the Firm Takes a Stance Against Market Maker Manipulation Practices

Published

on

Asia Broadband, Inc. (OTCMKTS: AABB)

Asia Broadband, Inc. (OTCMKTS: AABB) saw its stock price surge by over 10% in the last 24 hours following its decision to pursue market manipulation legal action against some major market makers. The firm’s stock price surged from $0.0290 to the current $0.0334, which was also the closing price on Thursday, March 9th. Before this, the firm’s price has had several spikes up over the last six months, although each of them was too sharp to last, and they were always followed by just as strong corrections. The last big example came around February 21st, with January 31st before that and January 17th before that.

To Find out the inside Scoop on AABB, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

The situation was slightly different in late 2022 when Asia Broadband saw a strong price surge around November 23rd, which led it to the high point of $0.0559 by December 6th. The following correction took the price back down to an average level of $0.033, with the price fluctuating around it until early February 2023. After that, the price sank to the support at $0.030, and it just broke it in the early days of March, going down to $0.028 before surging back up over the last two days.

Over the past six months or so, each of the strong price reactions that AABB has displayed took place roughly around the same time as some important events for the company. For example, in December 2022, the company launched the GoldenBaboons.com website in preparation for the launch of its Gold-Backed NFT Baboons collection, which went live in January. The collection Golden Baboons Mining Club (GBMC) was the first NFT collection that AABB has created and published. Furthermore, it is backed by gold, like the company’s AABBG token.

Another time the price had reacted was in January of this year, right after the reports of Asia Broadband completing a plant site purchase to process gold and silver ore. The firm announced the purchase of the new processing facility, and an evaluation report has estimated the stockpile to represent more than $800 million in gold and silver. Reports at the time have called the stockpile processing project the largest high-yield asset addition for the firm to date, and it was considered a part of its strategic expansion initiative, meant to help the Company acquire gold production and increase AABB’s physical gold holdings. Then, only about a week after that, new reports said that Asia Broadband is continuing its strategic expansion of its Central America cryptocurrency operations hub in El Salvador — specifically, in its Bitcoin City.

Finally, in mid-February, the company announced a registration deadline to purchase its gold-backed Baboons NFT collection during the NFT mint event. The deadline was February 22nd, and the minting took place after that, on February 28th. As for this latest AABB price surge, it came around the time when another new report emerged, stating that Asia Broadband pursues market manipulation legal action against major market makers for AABB shares on OTC Markets.

The legal initiative has actually progressed for months, as the company noted that many shareholders and public firms received expressing that the AABB share price was subjected to long-term repression by deceptive and false trading practices. Furthermore, other OTC Market issuers were already publicly exposed and legally challenged due to their market maker manipulation practices. Apart from that, Asia Broadband is also pursuing legal action against a number of parties for multiple defamatory internet posts.

The Company experienced similar defamation attacks several years ago, and the situation was resolved to the firm’s advantage, with the posts permanently removed. The company’s CEO and AABB President, Chris Torres, said:

We have an obligation to our shareholders to do everything in our power to protect their investments in our Company’s shares. Our share price is not reflecting the true value attributed to the Company’s successes in recent years due to deceitful and profiteering market manipulation.

While the name, Asia Broadband, Inc. (OTCMKTS: AABB), suggests that this is a telecommunications firm, AABB is actually a mining stock. Operating as a resource company with a special focus on the production, supply, and sale of precious and base metals, Asia Broadband primarily sells to Asian markets.

The firm uses specific geographic expertise, coupled with extensive industry contacts and a long and rich experience to facilitate innovative distribution processes from the production and supply of base and precious metals in Mexico to its clients, which can be found all over Asia. With that said, the company’s most prominent move as of late has been an attempt to develop a gold-backed cryptocurrency token and a gold-backed NFT collection mentioned earlier. The token itself is known as AABBG, and it was backed by $30 million in gold holdings as of 2021 when it was originally released.

For more on AABB Subscribe Right Now!

Despite the relatively poor stock price performance, Asia Broadband, Inc (OTCMKTS: AABB) is a mining firm that has great potential for the future. Its involvement with crypto assets and the fact that it supplies Asian clients both work in its favor. Asia is emerging as one of the leading regions in terms of technology and digital assets. With the company operating in the West on behalf of the East, it is in a perfect position to grow. Furthermore, if allegations of defamation and market manipulations from its lawsuit turn out to be true, that would explain the difficulties in AABB’s performance that the company has been facing, which could allow its stock to start growing once these negative aspects get removed. We will be updating on AABB when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with AABB.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in AABB, either long or short, and we have not been compensated for this article

Image by Tom und Nicki Löschner from Pixabay

Continue Reading

Trending

© All rights reserved.

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.